Oramed Gross Profit from 2010 to 2024

ORMP Stock  USD 2.34  0.03  1.30%   
Oramed Pharmaceuticals Gross Profit yearly trend continues to be relatively stable with very little volatility. Gross Profit is likely to drop to about 1.9 M. Gross Profit is the profit Oramed Pharmaceuticals makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals
 
Gross Profit  
First Reported
2012-03-31
Previous Quarter
666 K
Current Value
674 K
Quarterly Volatility
177.7 K
 
Yuan Drop
 
Covid
Check Oramed Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Oramed Pharmaceuticals' main balance sheet or income statement drivers, such as Selling General Administrative of 8.5 M, Other Operating Expenses of 52.3 M or Research Development of 7.6 M, as well as many indicators such as Price To Sales Ratio of 164, Dividend Yield of 0.0 or PTB Ratio of 2.92. Oramed financial statements analysis is a perfect complement when working with Oramed Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Oramed Pharmaceuticals Correlation against competitors.
To learn how to invest in Oramed Stock, please use our How to Invest in Oramed Pharmaceuticals guide.

Latest Oramed Pharmaceuticals' Gross Profit Growth Pattern

Below is the plot of the Gross Profit of Oramed Pharmaceuticals over the last few years. Gross profit is a required income statement account that reflects total revenue of Oramed Pharmaceuticals minus its cost of goods sold. It is profit before Oramed Pharmaceuticals operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Oramed Pharmaceuticals' Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Oramed Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 2.7 M10 Years Trend
Slightly volatile
   Gross Profit   
       Timeline  

Oramed Gross Profit Regression Statistics

Arithmetic Mean1,432,939
Geometric Mean711,099
Coefficient Of Variation87.15
Mean Deviation1,179,666
Median1,931,559
Standard Deviation1,248,813
Sample Variance1.6T
Range3M
R-Value0.86
Mean Square Error448.1B
R-Squared0.73
Significance0.000046
Slope239,107
Total Sum of Squares21.8T

Oramed Gross Profit History

20241.9 M
20233.1 M
20212.7 M
20202.6 M
20192.6 M
20182.4 M
20172.3 M

Other Fundumenentals of Oramed Pharmaceuticals

Oramed Pharmaceuticals Gross Profit component correlations

-0.930.770.970.990.10.480.990.690.91-0.050.330.950.750.980.94-0.71
-0.93-0.74-0.98-0.93-0.02-0.56-0.95-0.54-0.86-0.03-0.57-0.86-0.62-0.89-0.870.57
0.77-0.740.80.860.590.070.780.480.87-0.110.470.740.930.690.55-0.89
0.97-0.980.80.970.080.510.970.560.88-0.030.510.90.730.920.87-0.69
0.99-0.930.860.970.220.410.990.670.94-0.060.380.940.820.950.89-0.78
0.1-0.020.590.080.22-0.640.150.180.46-0.22-0.180.170.670.05-0.05-0.66
0.48-0.560.070.510.41-0.640.460.10.210.220.510.35-0.10.460.510.09
0.99-0.950.780.970.990.150.460.680.94-0.050.350.950.750.970.94-0.71
0.69-0.540.480.560.670.180.10.680.680.07-0.060.770.560.750.74-0.47
0.91-0.860.870.880.940.460.210.940.68-0.10.240.890.860.870.83-0.82
-0.05-0.03-0.11-0.03-0.06-0.220.22-0.050.07-0.10.2-0.04-0.21-0.05-0.020.27
0.33-0.570.470.510.38-0.180.510.35-0.060.240.20.180.180.220.17-0.2
0.95-0.860.740.90.940.170.350.950.770.89-0.040.180.760.980.92-0.64
0.75-0.620.930.730.820.67-0.10.750.560.86-0.210.180.760.70.55-0.95
0.98-0.890.690.920.950.050.460.970.750.87-0.050.220.980.70.97-0.64
0.94-0.870.550.870.89-0.050.510.940.740.83-0.020.170.920.550.97-0.51
-0.710.57-0.89-0.69-0.78-0.660.09-0.71-0.47-0.820.27-0.2-0.64-0.95-0.64-0.51
Click cells to compare fundamentals

About Oramed Pharmaceuticals Financial Statements

Oramed Pharmaceuticals shareholders use historical fundamental indicators, such as Gross Profit, to determine how well the company is positioned to perform in the future. Although Oramed Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. The changes in Oramed Pharmaceuticals' assets and liabilities, for example, are also reflected in the revenues and expenses on on Oramed Pharmaceuticals' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Gross Profit3.1 M1.9 M
Gross Profit Margin 0.87  0.65 

Pair Trading with Oramed Pharmaceuticals

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Oramed Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oramed Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.

Moving together with Oramed Stock

  0.66ME 23Andme HoldingPairCorr

Moving against Oramed Stock

  0.62BMY Bristol Myers Squibb Aggressive PushPairCorr
  0.48GILD Gilead SciencesPairCorr
  0.47EWTX Edgewise TherapeuticsPairCorr
The ability to find closely correlated positions to Oramed Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Oramed Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Oramed Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Oramed Pharmaceuticals to buy it.
The correlation of Oramed Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Oramed Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Oramed Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Oramed Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Oramed Stock Analysis

When running Oramed Pharmaceuticals' price analysis, check to measure Oramed Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oramed Pharmaceuticals is operating at the current time. Most of Oramed Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Oramed Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oramed Pharmaceuticals' price. Additionally, you may evaluate how the addition of Oramed Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.